findmyKOL

Arcot Dwarakanathan, MD, FACE

Basic profile

Rush University

ORCIDNone on fileNPI
RegionOlympia Fields, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Arcot Dwarakanathan is an Endocrinology/Metabolic physician affiliated with Rush University. OpenAlex indexes 16 publications with 326 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

326citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

20201 Crawford Ave
Olympia Fields, IL 604611010

Telephone

708-679-2130

Registry record last updated 24 Feb 2016.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    73.6%
    Biguanide (metformin)20.1%
    Metformin Hcl79%Metformin Hcl Er21%
    Part D138 patients
    Insulin Analog14.8%
    Tresiba Flextouch U-20020%Lantus Solostar15%Toujeo Solostar14%Toujeo Max Solostar12%Tresiba Flextouch U-10010%Humalog Kwikpen U-1008%Novolog Flexpen8%Basaglar Kwikpen U-1007%Fiasp Flextouch4%Lantus3%
    Part D<11 patients

    + 7 more classes in this area

  • Hormonal (systemic)

    20.6%
    l-Thyroxine17.7%
    Levothyroxine Sodium93%Synthroid7%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor2.1%
    Methimazole100%
    Part D19 patients

    + 1 more class in this area

  • Cardiovascular

    4.2%
    Statin1.6%
    Atorvastatin Calcium73%Simvastatin27%
    Part D<11 patients
    Calcium channel blocker0.8%
    Amlodipine Besylate100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”